Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126800031 | 12680003 | 1 | I | 20160817 | 20160824 | 20160824 | EXP | CA-AMGEN-CANSP2016108142 | AMGEN | 0.00 | F | Y | 0.00000 | 20160824 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126800031 | 12680003 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 126800031 | 12680003 | 2 | SS | ABATACEPT | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, Q4WK | 0 | 750 | MG | ||||||||
| 126800031 | 12680003 | 3 | SS | CODEINE | CODEINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 126800031 | 12680003 | 5 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 2 MG, QD | 0 | 2 | MG | QD | |||||||
| 126800031 | 12680003 | 6 | C | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126800031 | 12680003 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | |||||||||||
| 126800031 | 12680003 | 8 | C | CARBIDOPA/LEVODOPA | CARBIDOPALEVODOPA | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 9 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 10 | C | CLARITIN | LORATADINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 11 | C | FERROUS FUMARATE | FERROUS FUMARATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 12 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 13 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 14 | C | LOSEC | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 15 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 16 | C | PREVACID | LANSOPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 17 | C | REACTINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 18 | C | SINEMET | CARBIDOPALEVODOPA | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126800031 | 12680003 | 19 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126800031 | 12680003 | 20 | C | BUDESONIDE W/FORMOTEROL FUMARATE | BUDESONIDEFORMOTEROL FUMARATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126800031 | 12680003 | 1 | Rheumatoid arthritis |
| 126800031 | 12680003 | 2 | Rheumatoid arthritis |
| 126800031 | 12680003 | 3 | Product used for unknown indication |
| 126800031 | 12680003 | 4 | Rheumatoid arthritis |
| 126800031 | 12680003 | 5 | Rheumatoid arthritis |
| 126800031 | 12680003 | 6 | Product used for unknown indication |
| 126800031 | 12680003 | 7 | Product used for unknown indication |
| 126800031 | 12680003 | 8 | Product used for unknown indication |
| 126800031 | 12680003 | 9 | Product used for unknown indication |
| 126800031 | 12680003 | 10 | Product used for unknown indication |
| 126800031 | 12680003 | 11 | Product used for unknown indication |
| 126800031 | 12680003 | 12 | Product used for unknown indication |
| 126800031 | 12680003 | 13 | Product used for unknown indication |
| 126800031 | 12680003 | 14 | Product used for unknown indication |
| 126800031 | 12680003 | 15 | Product used for unknown indication |
| 126800031 | 12680003 | 16 | Product used for unknown indication |
| 126800031 | 12680003 | 17 | Product used for unknown indication |
| 126800031 | 12680003 | 18 | Product used for unknown indication |
| 126800031 | 12680003 | 19 | Product used for unknown indication |
| 126800031 | 12680003 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126800031 | 12680003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126800031 | 12680003 | C-reactive protein abnormal | |
| 126800031 | 12680003 | Dermatitis psoriasiform | |
| 126800031 | 12680003 | Drug ineffective | |
| 126800031 | 12680003 | Hepatic enzyme increased | |
| 126800031 | 12680003 | Pain in extremity | |
| 126800031 | 12680003 | Psoriasis | |
| 126800031 | 12680003 | Red blood cell sedimentation rate abnormal | |
| 126800031 | 12680003 | Rheumatoid arthritis | |
| 126800031 | 12680003 | Skin depigmentation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |